Composition, sequencing and ion mobility mass spectrometry of heparan sulfatelike octasaccharide isomers differing in glucuronic and iduronic acid content

European Journal of Mass Spectrometry

Volumn 21, Issue 3, 2015, Pages 245-254

  Miller, Rebecca L ^a,b   Wei, Wei ^a   Schwörer, Ralf ^c   Zubkova, Olga V ^c   Tyler, Peter C ^c   Turnbull, Jeremy E ^b   Leary, Julie A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Arrival time distribution; Electron detachment dissociation; Glucuronic acid; Glycosaminoglycan; Heparan sulfate; Iduronicacid; IMMS; MS2

Indexed keywords

GLUCOSE; HYDRAULIC STRUCTURES; ION MOBILITY SPECTROMETERS; ISOMERS; MASS SPECTROMETRY; OLIGOSACCHARIDES; SULFUR COMPOUNDS;

ARRIVAL-TIME DISTRIBUTIONS; ELECTRON DETACHMENT DISSOCIATIONS; GLUCURONIC ACIDS; GLYCOSAMINOGLYCANS; HEPARAN SULFATES; IDURONICACID; IMMS; MS^2;

IONS;

GLUCURONIC ACID; HEPARAN SULFATE; IDURONIC ACID; POLYSACCHARIDE;

BINDING SITE; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; ISOMERISM; PROCEDURES; SEQUENCE ANALYSIS;

BINDING SITES; GLUCURONIC ACID; HEPARITIN SULFATE; IDURONIC ACID; ISOMERISM; POLYSACCHARIDES; SEQUENCE ANALYSIS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84952714384     PISSN: 14690667     EISSN: 17516838     Source Type: Journal    
DOI: 10.1255/ejms.1337     Document Type: Article

References (49)

1. O. N. El-Assal, A. Radulescu and G. E. Besner, "Heparinbinding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation", Surgery 142, 234 (2007). doi: http://dx.doi.org/10.1016/j.surg.2007.04.003
2. D. V. Rocourt, V. B. Mehta and G. E. Besner, "Heparinbinding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury", J. Surg. Res. 139, 269 (2007). doi: http://dx.doi.org/10.1016/j.jss.2006.10.047
3. U. Lindahl, L. Thunberg, G. Backstrom and J. Riesenfeld, "The antithrombin-binding sequence of heparin", Biochem. Soc. Trans. 9, 499 (1981). doi: http://dx.doi.org/10.1042/bst0090499
4. R. Copeland, A. Balasubramaniam, V. Tiwari, F. Zhang, A. Bridges, R. J. Linhardt, D. Shukla and J. Liu, "Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of Herpes simplex virus type 1", Biochemistry 47, 5774 (2008). doi: http://dx.doi.org/10.1021/bi800205t
5. A. Ori, M. C. Wilkinson and D. G. Fernig, "The heparanome and regulation of cell function: structures, functions and challenges", Front. Biosci. 13, 4309 (2007). doi: http://dx.doi.org/10.2741/3007
6. M. Klagsbrun, "Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (BFGF) - heparin and heparan sulfate interactions", Semin. Cancer Biol. 1992, 81 (1992).
7. T. Sasaki, H. Larsson, J. Kreuger, M. Salmivirta, L. Claesson-Welsh, U. Lindahl, E. Hohenester and R. Timpl, "Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin", EMBO J. 18, 6240 (1999). doi: http://dx.doi.org/10.1093/emboj/18.22.6240
8. Z. Hu, C. Wang, Y. Xiao, N. Sheng, Y. Chen, Y. Xu, L. Zhang, W. Mo, N. Jing and G. Hu, "NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development", J. Cell Sci. 122, 1145 (2009). doi: http://dx.doi.org/10.1242/jcs.034736
9. H. Zhou, S. Roy, E. Cochran, R. Zouaoui, C. L. Chu, J. Duffner, G. Zhao, S. Smith, Z. Galcheva-Gargova and J. Karlgren, "M402, a novel heparan sulfate mimetic, targetsmultiple pathways implicated in tumor progression and metastasis", PLoS ONE 6, e21106 (2011). doi: http://dx.doi.org/10.1371/journal.pone.0021106
10. L. Jin, J. P. Abrahams, R. Skinner, M. Petitou, R. N. Pike and R. W. Carrell, "The anticoagulant activationof antithrombin by heparin", Proc. Natl. Acad. Sci. 94, 14683 (1997). doi: http://dx.doi.org/10.1073/pnas.94.26.14683
11. M. Petitou, B. Casu and U. Lindahl, "1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site", Biochimie 85, 83 (2003). doi: http://dx.doi.org/10.1016/S0300-9084 (03) 00078-6
12. K. J. Bame, I. Venkatesan, H. D. Stelling and S. Tumova, "The spacing of S-domains on HS glycosaminoglycans determines whether the chain is a substrate for intracellular heparanases", Glycobiology 10, 715 (2000). doi: http://dx.doi.org/10.1093/glycob/10.7.715
13. M. Lyon and J. T. Gallagher, "Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion", Matrix Biol. 17, 485 (1998). doi: http://dx.doi.org/10.1016/S0945-053X (98) 90096-8
14. D. H. Atha, J. C. Lormeau, M. Petitou, R. D. Rosenberg and J. Choay, "Contribution of monosaccharide residues in heparin binding to antithrombin III", Biochemistry 24, 6723 (1985). doi: http://dx.doi.org/10.1021/bi00344a063
15. U. Lindahl, G. Bäckström and L. Thunberg, "The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group", J. Biol. Chem. 258, 9826 (1983).
16. U. Lindahl, G. Bäckström, L. Thunberg and I. G. Leder, "Evidence for a 3-O-sulfated d-glucosamine residue in the antithrombin-binding sequence of heparin", Proc. Natl. Acad. Sci. 77, 6551 (1980). doi: http://dx.doi.org/10.1073/pnas.77.11.6551
17. M. Petitou, P. Duchaussoy, I. Lederman, J. Choay and P. Siná, "Binding of heparin to antithrombin III: a chemical proof of the critical role played by a 3-sulfated 2-amino-2-deoxy-d-glucose residue", Carbohydr. Res. 179, 163 (1988). doi: http://dx.doi.org/10.1016/0008-6215 (88) 84116-8
18. J. Riesenfeld, L. Thunberg, M. Höök and U. Lindahl, "The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups", J. Biol. Chem. 256, 2389 (1981).
19. C. L. Merry, M. Lyon, J. A. Deakin, J. J. Hopwood and J. T. Gallagher, "Highly sensitive sequencing of the sulfated domains of heparan sulfate", J. Biol. Chem. 274, 18455 (1999). doi: http://dx.doi.org/10.1074/jbc.274.26.18455
20. O. M. Saad, H. Ebel, K. Uchimura, S. D. Rosen, C. R. Bertozzi and J. A. Leary, "Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase", Glycobiology 15, 818 (2005). doi: http://dx.doi.org/10.1093/glycob/cwi064
21. O. M. Saad and J. A. Leary, "Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry", Anal. Chem. 75, 2985 (2003). doi: http://dx.doi.org/10.1021/ac0340455
22. O. M. Saad and J. A. Leary, "Delineating mechanisms of dissociation for isomeric heparin disaccharides using isotope labeling and ion trap tandem mass spectrometry", J. Am. Soc. Mass Spectrom. 15, 1274 (2004). doi: http://dx.doi.org/10.1016/j.jasms.2004.05.008
23. O. M. Saad and J. A. Leary, "Heparin sequencing using enzymatic digestion and ESI-MSn with host: a heparin/HS oligosaccharide sequencing tool", Anal. Chem. 77, 5902 (2005). doi: http://dx.doi.org/10.1021/ac050793d
24. M. R. Schenauer, J. K. Meissen, Y. Seo, J. B. Ames and J. A. Leary, "Heparan sulfate separation, sequencing, and isomeric differentiation: ion mobility spectrometry reveals specific iduronic and glucuronic acid-containing hexasaccharides", Anal. Chem. 81, 10179 (2009). doi: http://dx.doi.org/10.1021/ac902186h
25. Y. Seo, A. Andaya and J. A. Leary, "Preparation, separation, and conformational analysis of differentially sulfated heparin octasaccharide isomers using ion mobility mass spectrometry", Anal. Chem. 84, 2416 (2012). doi: http://dx.doi.org/10.1021/ac203190k
26. R. Vives, D. Pye, M. Salmivirta, J. Hopwood, U. Lindahl and J. Gallagher, "Sequence analysis of heparan sulphate and heparin oligosaccharides", Biochem. J. 339, 767 (1999). doi: http://dx.doi.org/10.1042/0264-6021:3390767
27. J. E. Turnbull, J. J. Hopwood and J. T. Gallagher, "A strategy for rapid sequencing of heparan sulfate and heparin saccharides", Proc. Natl. Acad. Sci. 96, 2698 (1999). doi: http://dx.doi.org/10.1073/pnas.96.6.2698
28. G. Venkataraman, Z. Shriver, R. Raman and R. Sasisekharan, "Sequencing complex polysaccharides", Science 286, 537 (1999). doi: http://dx.doi.org/10.1126/science. 286.5439.537
29. M. Hricovíni and G. Torri, "Dynamics in aqueous solutions of the pentasaccharide corresponding to the binding site of heparin for antithrombin III studied by NMR relaxation measurements", Carbohydr. Res. 268, 159 (1995). doi: http://dx.doi.org/10.1016/0008-6215 (94) 00334-C
30. F. E. Leach III, S. Arungundram, K. Al-Mafraji, A. Venot, G.-J. Boons and I. J. Amster, "Electron detachment dissociation of synthetic heparan sulfate glycosaminoglycan tetrasaccharides varying in degree of sulfation and hexuronic acid stereochemistry", Int. J. Mass Spectrom. 330, 152 (2012). doi: http://dx.doi.org/10.1016/j. ijms.2012.07.002
31. B. Mulloy and M. J. Forster, "Conformation and dynamics of heparin and heparan sulfate", Glycobiology 10, 1147 (2000). doi: http://dx.doi.org/10.1093/glycob/10.11.1147
32. H. B. Oh, F. E. Leach III, S. Arungundram, K. Al-Mafraji, A. Venot, G.-J. Boons and I. J. Amster, "Multivariate analysis of electron detachment dissociation and infrared multiphoton dissociation mass spectra of heparan sulfate tetrasaccharides differing only in hexuronic acid stereochemistry", J. Am. Soc. Mass Spectrom. 22, 582 (2011). doi: http://dx.doi.org/10.1007/s13361-010-0047-y
33. J. J. Wolff, L. Chi, R. J. Linhardt and I. J. Amster, "Distinguishing glucuronic from iduronic acid in glycosaminoglycan tetrasaccharides by using electron detachmentdissociation", Anal. Chem. 79, 2015 (2007). doi: http://dx.doi.org/10.1021/ac061636x
34. F. E. Leach III, J. J. Wolff, Z. Xiao, M. Ly, T. N. Laremore, S. Arungundram, K. Al-Mafraji, A. Venot, G.-J. Boons and R. J. Linhardt, "Negative electron transfer dissociationFourier transform mass spectrometry of glycosaminoglycancarbohydrates", Eur. J. Mass Spectrom. 17, 167 (2011). doi: http://dx.doi.org/10.1255/ejms.1120
35. J. J. Wolff, F. E. Leach III, T. N. Laremore, D. A. Kaplan, M. L. Easterling, R. J. Linhardt and I. J. Amster, "Negative electron transfer dissociation of glycosaminoglycans", Anal. Chem. 82, 3460 (2010). doi: http://dx.doi.org/10.1021/ac100554a
36. J. J. Wolff, I. J. Amster, L. Chi and R. J. Linhardt, "Electron detachment dissociation of glycosaminoglycan tetrasaccharides", J. Am. Soc. Mass Spectrom. 18, 234 (2007). doi: http://dx.doi.org/10.1016/j.jasms.2006.09.020
37. J. J. Wolff, T. N. Laremore, A. M. Busch, R. J. Linhardt and I. J. Amster, "Electron detachment dissociation of dermatan sulfate oligosaccharides", J. Am. Soc. Mass Spectrom. 19, 294 (2008). doi: http://dx.doi.org/10.1016/j. jasms.2007.10.007
38. J. J. Wolff, T. N. Laremore, H. Aslam, R. J. Linhardt and I. J. Amster, "Electron-induced dissociation of glycosaminoglycan tetrasaccharides", J. Am. Soc. Mass Spectrom. 19, 1449 (2008). doi: http://dx.doi.org/10.1016/j. jasms.2008.06.024
39. E. Atkins and T. Laurent, "X-ray diffraction patterns from chondroitin 4-sulphate, dermatan sulphate and heparan sulphate", Biochem. J. 133, 605 (1973).
40. D. R. Ferro, A. Provasoli, M. Ragazzi, B. Casu, G. Torri, V. Bossennec, B. Perly, P. Siná, M. Petitou and J. Choay, "Conformer populations of l-iduronic acid residues in glycosaminoglycan sequences", Carbohydr. Res. 195, 157 (1990). doi: http://dx.doi.org/10.1016/0008-6215 (90) 84164-P
41. P. N. Sanderson, T. N. Huckerby and I. A. Nieduszynski, "Conformational equilibria of alpha-l-iduronate residues in disaccharides derived from heparin", Biochem. J. 243, 175 (1987).
42. E. A. Yates, F. Santini, M. Guerrini, A. Naggi, G. Torri and B. Casu, "1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives", Carbohydr. Res. 294, 15 (1996). doi: http://dx.doi.org/10.1016/S0008-6215 (96) 90611-4
43. Y. Seo, A. Andaya, C. Bleiholder and J. A. Leary, "Differentiation of CC vs CXC chemokine dimers with GAG octasaccharide binding partners: an ion mobility mass spectrometry approach", J. Am. Chem. Soc. 135, 4325 (2013). doi: http://dx.doi.org/10.1021/ja310915m
44. Y. Seo, M. R. Schenauer and J. A. Leary, "Biologically relevant metal-cation binding induces conformational changes in heparin oligosaccharides as measured by ion mobility mass spectrometry", Int. J. Mass Spectrom. 303, 191 (2011). doi: http://dx.doi.org/10.1016/j. ijms.2011.02.003
45. J. Ujma, M. De Cecco, O. Chepelin, H. Levene, C. Moffat, S. J. Pike, P. J. Lusby and P. E. Barran, "Shapes of supramolecular cages by ion mobility mass spectrometry", Chem. Commun. 48, 4423 (2012). doi: http://dx.doi.org/10.1039/C2CC30778B
46. L. Jin, P. E. Barran, J. A. Deakin, M. Lyon and D. Uhrín, "Conformation of glycosaminoglycans by ion mobility mass spectrometry and molecular modelling", Phys. Chem. Chem. Phys. 7, 3464 (2005). doi: http://dx.doi.org/10.1039/B508644B
47. E. Jurneczko, J. Kalapothakis, I. D. Campuzano, M. Morris and P. E. Barran, "Effects of drift gas on collision cross sections of a protein standard in linear drift tube and traveling wave ion mobility mass spectrometry", Anal. Chem. 84, 8524 (2012). doi: http://dx.doi.org/10.1021/ac301260d
48. R. Schwörer, O. V. Zubkova, J. E. Turnbull and P. C. Tyler, "Synthesis of a targeted library of heparan sulfate hexabto dodecasaccharides as inhibitors of b-secretase: potential therapeutics for Alzheimer's disease", Chem. Eur. J. 19, 6817 (2013). doi: http://dx.doi.org/10.1002/chem.201204519
49. B. Domon and C. E. Costello, "Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry", Biochemistry 27, 1534 (1988). doi: http://dx.doi.org/10.1021/bi00405a021